ENTA
Enanta Pharmaceuticals
$12.73
−$0.05 (−0.39%)Jul 27, 2026
Key metrics
The numbers that frame ENTA today
- Market cap
- $370.17M
- P/E (TTM)
- -6.0
- EV / FCF
- -40.8
- Gross margin
- 100%
- EV / Sales
- 5.7
- ROIC
- -18.4%
- Div yield
- 0%
- Debt / equity
- 0.5
- 52wk Low
- $6.45
- 52wk High
- $17.15
Growth
Revenue and earnings trend for ENTA
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about ENTA
Is Enanta Pharmaceuticals a good buy?
Yes. Enanta Pharmaceuticals has mixed quality and excellent momentum. Taken together, the setup leans positive. Growth looks excellent, which supports the long-term business case. We think Enanta Pharmaceuticals is selling at a high price, which cuts against the buy case.
What is the market capitalization of ENTA?
Enanta Pharmaceuticals's market capitalization is $370.17M.
What is the P/E ratio for ENTA stock?
Enanta Pharmaceuticals's current P/E ratio is -6.
What is the 52-week high for ENTA stock?
The 52-week high for Enanta Pharmaceuticals is $17.15. The current close of $12.73 is 25.8% below that high.
What is the 52-week low for ENTA stock?
The 52-week low for Enanta Pharmaceuticals is $6.45. The current close of $12.73 is 97.4% above that low.
Does ENTA stock pay dividends?
Enanta Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ENTA?
Enanta Pharmaceuticals's Debt / Equity ratio is 0.49.